ClinConnect ClinConnect Logo
Search / Trial NCT06910189

Use of Fish Skin Graft (FSG) to Improve Wound Healing and Expedite Discharge at a County Safety-net Hospital

Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER, HOUSTON · Mar 27, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Fish Skin Graft (Fsg) Kerecis

ClinConnect Summary

This clinical trial is looking at a new treatment using fish skin grafts (FSG) to help heal large surgical wounds and potentially allow patients to leave the hospital sooner. The study will involve adult patients who have a surgical wound that is at least 40 square centimeters and needs a special cleaning procedure called surgical debridement.

To participate, patients should be between 65 and 74 years old, have a wound that meets the size requirement, and be willing to follow up for up to a year after treatment. However, those with wounds that don’t need surgery, allergies to fish, or who may have trouble following up (like those living out of state or in police custody) won’t be eligible. Participants can expect close monitoring and support throughout the trial to help assess how well the fish skin graft works for their healing process.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Has wound greater than or equal to 40cm2 requiring surgical debridement
  • Agreeable to follow up period of up to 1 year
  • Exclusion Criteria:
  • Patients with wounds that do not require surgical debridement.
  • Patients with a known allergy or other sensitivity to fish material
  • Patients who are deemed unlikely to follow up (e.g., patients who live out of state).
  • Patients in police custody/incarcerated.
  • Patients unable to communicate in either Spanish or English.

About The University Of Texas Health Science Center, Houston

The University of Texas Health Science Center at Houston (UTHealth) is a leading academic institution dedicated to advancing health through education, research, and clinical practice. As a prominent sponsor of clinical trials, UTHealth leverages its extensive resources and expertise in biomedical research to facilitate innovative studies aimed at improving patient outcomes. The institution is committed to fostering a collaborative environment that promotes scientific discovery and the translation of research findings into effective healthcare solutions, all while adhering to the highest ethical standards and regulatory guidelines. With a multidisciplinary approach, UTHealth plays a critical role in addressing complex health challenges and enhancing the quality of life in diverse communities.

Locations

Houston, Texas, United States

Patients applied

0 patients applied

Trial Officials

Jonah Stulberg, MD

Principal Investigator

The University of Texas Health Science Center, Houston

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported